What is the effect of self-identified HIV activism in willingness to participate in HIV cure-related clinical trials? Results from the ANRS-APSEC study

scientific article published on 18 September 2019

What is the effect of self-identified HIV activism in willingness to participate in HIV cure-related clinical trials? Results from the ANRS-APSEC study is …
instance of (P31):
editorialQ871232
scholarly articleQ13442814

External links are
P932PMC publication ID6816119
P698PubMed publication ID31700661

P50authorCécile GoujardQ88521925
Lisa FressardQ105256291
P2093author name stringBruno Spire
Luis Sagaon-Teyssier
Olivier Lambotte
Laurence Meyer
Christel Protière
Marion Fiorentino
Marie Préau
Marie Suzan-Monti
Michael P Arnold
Mohamed Mimi
Sylvie Fainzang
Janine Barbot
P2860cites workLife expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studiesQ24597052
Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantationQ29615068
Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participationQ30233275
Designing research in vulnerable populations: lessons from HIV prevention trials that stopped earlyQ30476516
Spirituality, social capital and service: factors promoting resilience among Expert Patients living with HIV in EthiopiaQ33662720
Clinical trials in the 21st century: the case for participant-centered researchQ34464504
Resilience processes demonstrated by young gay and bisexual men living with HIV: implications for interventionQ34606532
Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI StudyQ34629153
What determines health-related quality of life among people living with HIV: an updated review of the literatureQ35068416
Challenging the paradigm: anthropological perspectives on HIV as a chronic disease.Q35327005
Four models of the physician-patient relationshipQ35965482
Towards Multidisciplinary HIV-Cure Research: Integrating Social Science with Biomedical ResearchQ36421142
Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic reviewQ37002937
Recruitment and ethical considerations in HIV cure trials requiring treatment interruptionQ37098218
International AIDS Society global scientific strategy: towards an HIV cure 2016.Q37661770
Elite controllers as a model of functional cureQ37860878
Epidemiology and clinical characteristics of elite controllersQ37866623
HIV infection associated post-traumatic stress disorder and post-traumatic growth--a systematic reviewQ37906627
Obstacles to participation in randomised cancer clinical trials: a systematic review of the literatureQ37984632
Correlates of post-traumatic stress symptoms and growth in cancer patients: a systematic review and meta-analysisQ38267863
"We Need to Deploy Them Very Thoughtfully and Carefully": Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States-A Qualitative InquiryQ38754318
Resilience factors associated with adaptation to HIV diseaseQ39263448
Social support, stress coping strategies, resilience and posttraumatic growth in a Polish sample of HIV-infected individuals: results of a 1 year longitudinal studyQ39307725
Will CURE trials introduce an uncomfortable revolution in the field of HIV research?Q40170563
Patients' preferences for the management of non-metastatic prostate cancer: discrete choice experimentQ40569730
A global survey of HIV-positive people's attitudes towards cure research.Q40679206
Community advisory boards: their role in AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS.Q40833636
Willingness to participate and take risks in HIV cure research: survey results from 400 people living with HIV in the US.Q42318290
Controversies in HIV cure researchQ43149657
Past, present and future: 30 years of HIV researchQ44302465
On the undecidability among kinetic models: from model selection to model averagingQ44393049
Disputing the ethics of research: the challenge from bioethics and patient activism to the interpretation of the Declaration of Helsinki in clinical trialsQ45386990
HIV vaccine trial participation among ethnic minority communities: barriers, motivators, and implications for recruitmentQ46965041
Social support and posttraumatic growth in a longitudinal study of people living with HIV: the mediating role of positive affectQ47130549
Patterns of patient and healthcare provider viewpoints regarding participation in HIV cure-related clinical trials. Findings from a multicentre French survey using Q methodology (ANRS-APSEC).Q47150619
How to build an "active" patient? The work of AIDS associations in FranceQ47260702
Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessmentQ47307973
Acceptability of HIV cure-related trials: the challenges for physicians and people living with HIV (ANRS-APSEC).Q47551738
Importance of the patient-physician interaction in assessing acceptability of HIV cure trials.Q47736521
What can the lived experience of participating in risky HIV cure-related studies establish?Q47739874
Trauma and growth in Canadian carers.Q51018629
Factors contributing to posttraumatic growth: a proposed structural equation model.Q51019891
HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy.Q51320237
HIV Infection: Advances Toward a Cure.Q54967198
Trauma and Growth: Impact of AIDS Activism.Q55476370
Perceptions of HIV cure research among people living with HIV in AustraliaQ58003755
A longitudinal analysis of posttraumatic growth and affective well-being among people living with HIV: The moderating role of received and provided social supportQ58122637
Variable selection and Bayesian model averaging in case-control studiesQ60373535
The construction of lay expertise: AIDS activism and the forging of credibility in the reform of clinical trialsQ74787577
Methodological issues in the application of conjoint analysis in health careQ74820029
Participation in cancer clinical trials: race-, sex-, and age-based disparitiesQ80179103
P433issue3
P304page(s)152-162
P577publication date2019-09-18
P1433published inJournal of virus eradicationQ27726372
P1476titleWhat is the effect of self-identified HIV activism in willingness to participate in HIV cure-related clinical trials? Results from the ANRS-APSEC study
P478volume5

Search more.